ACCELERO: Ph1b/2 Study of Disitamab Vedotin in HER2 Breast Cancer
Phase II Clinical Trial
A PHASE 1B/2 OPEN-LABEL MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER.(C5731006/SGNDV-006)
Participating Locations